Back to Search
Start Over
OctoPlus' licensee Biolex completes patient enrollment in Phase IIb study with Locteron
- Source :
- Internet Wire. June 29, 2009
- Publication Year :
- 2009
-
Abstract
- LEIDEN, NETHERLANDS, Jun 29, 2009 (MARKETWIRE via COMTEX) -- OctoPlus N.V. ('OctoPlus') (Euronext: OCTO) announces today that its licensee Biolex Therapeutics (see separate Biolex press release on www.biolex.com) has completed […]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Internet Wire
- Publication Type :
- News
- Accession number :
- edsgcl.202554407